Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G.J. Braunstahl, M. Deenstra, J. Canvin, P. Georgiou, G. Peachey, C.W. Chen (Rotterdam, Almere, Netherlands; Horsham, United Kingdom; East Hanover, United States Of America). Improvements in asthma control and quality of life with omalizumab in allergic (IgE-mediated) asthma patients. Eur Respir J 2012; 40: Suppl. 56, 1793

Member's Comments

No comment yet.

Related content which might interest you: The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma Source: Eur Respir J 2002; 20: 1088-1094 Year: 2002 Effectiveness of omalizumab in improving quality of life in patients with ‘steroid-resistant‘ asthma and severe allergic rhinitis Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Improvement of control and quality of life in severe allergic asthmatics patients treated with omalizumab Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 Quality of life in children with asthma associated with allergic rhinitis Source: Annual Congress 2009 - How viruses, allergic rhinitis and air pollution affect childhood asthma Year: 2009 Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma Source: Eur Respir J 2002; 20: 73-78 Year: 2002 Omalizumab improves asthma-specific quality of life in patients with severe allergic asthma Source: Eur Respir J 2001; 18: Suppl. 33, 37s Year: 2001 Persistency of treatment response to omalizumab in patients with severe allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Treatment and outcomes in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005 The effect of allergic rhinitis on quality of life and sleep quality in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 443s Year: 2006 The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004 Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma at a single UK hospital Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Evaluation of asthma patients using the control of allergic rhinitis and asthma test (CARAT) Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Quality of life in school children with atopic asthma and allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 852s Year: 2006 Effect of omalizumab treatment on allergic comorbidities in patients with severe allergic asthma – real life experience from Czech Anti-IgE Registry Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Predictors of work-related sensitisation, allergic rhinitis and asthma in early work life Source: Eur Respir J 2014; 44: 657-665 Year: 2014 Rhinoconjunctivitis quality of life (RCQOL) in allergic rhinitis & its impact on childhood asthma Source: Eur Respir J 2006; 28: Suppl. 50, 255s Year: 2006 Improved symptom relief with omalizumab in the treatment of allergic rhinitis Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006